Health Sciences In The Media

Experts including Deepta Bhattacharya, PhD, professor of immunobiology at the College of Medicine – Tucson, discuss gene-editing strategies that allow stem cells to evade the immune system.

Rachna Shroff, MD, discussed updated data on tinengotinib, an FGFR inhibitor that has demonstrated notable responses in patients with FGFR-altered cholangiocarcinoma.

Frank A. von Hippel, PhD, is interviewed about the Spanish-language edition of his book, “The Chemical Age: How Chemists Fought Famine and Disease, Killed Millions, and Changed Our Relationship with the Earth.”

Experts including Mohab Ibrahim, MD, PhD, discuss signs to look for and what to expect from migraines that necessitate a trip to the hospital.

Experts including Rubin Naiman, PhD, discuss the purpose and psychological implications of dreams.

Heather Cassell, MD, commented on a new study that says omalizumab, a drug approved to treat allergic asthma and chronic hives, can limit children’s dangerous allergic responses to small amounts of allergy-triggering foods.

Research from the UArizona Health Sciences Comprehensive Center for Pain & Addiction found that green light therapy may provide benefits in the treatment of recurrent migraines.

Vlad Kalinichenko, MD, PhD, director of the Phoenix Children's Research Institute and professor of child health at the College of Medicine – Phoenix, received a $3 million grant from the National Heart, Lung and Blood Institute to develop new treatment methods for lung disease in premature infants.

Victoria Maizes, MD, executive director of the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson, is interviewed about topics including the health benefits of staying active.

HonorHealth Research Institute plans to offer the T cell therapy lifileucel to treat melanoma that cannot be surgically removed or that has spread to other parts of the body. The product is the first T cell immunotherapy to receive FDA approval for a solid tumor cancer.